# Evaluation of Ventricular Pacing Suppression Algorithms in Dual Chamber Pacemaker

Study · id `cardio:ct-nct03843242` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT03843242](<https://clinicaltrials.gov/study/NCT03843242>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT03843242

Browse, organ or system: Heart  
Browse, condition area: Heart rhythm problems; Heart failure  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 146 participants.

## Technical summary

Registry record NCT03843242. Randomized; single masking; primary purpose diagnostic. Start 2019-05-30 (actual); primary completion 2021-06-24 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose diagnostic
- Phase: Not applicable
- Enrolled: 146 participants (enrolled count; ClinicalTrials.gov record NCT03843242, source copy `cardio:ctgov-nct03843242-2023-05-31`, retrieved 2026-10-26)
- Started: 2019-05-30 (actual) (ClinicalTrials.gov record NCT03843242, source copy `cardio:ctgov-nct03843242-2023-05-31`, retrieved 2026-10-26)
- Primary completion: 2021-06-24 (actual) (ClinicalTrials.gov record NCT03843242, source copy `cardio:ctgov-nct03843242-2023-05-31`, retrieved 2026-10-26)
- Completion: 2022-11-23 (actual) (ClinicalTrials.gov record NCT03843242, source copy `cardio:ctgov-nct03843242-2023-05-31`, retrieved 2026-10-26)
- Countries: South Korea (ClinicalTrials.gov record NCT03843242, source copy `cardio:ctgov-nct03843242-2023-05-31`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct03843242-2023-05-31`, retrieved 2026-10-26)

## The registry's words

- Brief title: Evaluation of Ventricular Pacing Suppression Algorithms in Dual Chamber Pacemaker
- Acronym: LEADER
- Condition: Sick Sinus Syndrome
- Condition: Pacemaker
- Condition: Heart Failure
- Intervention (Device): Pacemaker with Fixed long AV delay
- Intervention (Device): Pacemaker with VpS® algorithm on
- Intervention (Device): Pacemaker with IRSplus algorithm on
- Lead sponsor: Keimyung University Dongsan Medical Center
- Lead sponsor class: OTHER
- Collaborator: Biotronik SE & Co. KG
- Collaborator class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Arrhythmia (heart rhythm problems) (`cardio:arrhythmia`)
- Registry condition terms include this condition: Heart failure (`cardio:heart-failure`)
- Registry condition terms include this condition: Sick sinus syndrome (`cardio:sick-sinus-syndrome`)
- Registry lists this organization as the lead sponsor: Keimyung University Dongsan Medical Center (`cardio:org-keimyung-university-dongsan-medical-center`)
- Registry lists this organization as a collaborator: Biotronik SE & Co. KG (`cardio:org-biotronik-se-co-kg`)

## Provenance

Content hash: fa85745cc13a0fb3ea3d0cf60b4f49e5ebfb3a7742d855c6d6412019d9b4c13f
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
